prof. Valerie Fonteyne

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Valerie Fonteyne (UGent) , C Berghen, Charles Van Praet (UGent) , Barbara Vanderstraeten (UGent) , Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Roos Colman (UGent) , Ben Vanneste (UGent) , Piet Ost (UGent) , G De Meerleer, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 193.

Add to list

Journal Article
A1
open access

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice

Flor Verghote (UGent) , Charles Van Praet (UGent) , Camille Berquin (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Ben Vanneste (UGent) , Elke Rammant (UGent) and Valerie Fonteyne (UGent)

(2024) BMC CANCER. 24(1).

Add to list

Journal Article
A1
open access

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

Renée Bultijnck (UGent) , Mieke Van Hemelrijck, Valerie Fonteyne (UGent) , Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, et al.

(2024) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 45.

Add to list

PI-RADS 5 in prostate magnetic resonance imaging : how important is intraprostatic invasive behavior?

Ottavia Battaglia, Pieter De Visschere (UGent) , Sifrid Hendrickx (UGent) , Valerie Fonteyne (UGent) , Sofie Verbeke (UGent) , Charles Van Praet (UGent) and Geert Villeirs (UGent)

(2024) European Congress of Radiology 2024 (ECR 2024), Abstracts.

Add to list

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2024) EUROPEAN UROLOGY ONCOLOGY. 7(3). p.462-468

Add to list

Definition and diagnosis of oligometastatic bladder cancer : a Delphi consensus study endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

Aristotelis Bamias, Arnulf Stenzl, Stephanie L. Brown, Laurence Albiges, Marko Babjuk, Alison Birtle, Alberto Briganti, Maximilian Burger, Ananya Choudhury, Maurizio Colecchia, et al.

(2023) EUROPEAN UROLOGY. 84(4). p.381-389

Add to list

Journal Article
A1
open access

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal Shore, Eric Small, Matthew Smith, et al.

(2023) EUROPEAN JOURNAL OF CANCER. 185. p.178-215

Add to list

Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Philip Sutera, Kim Van der Eecken (UGent) , Amol Shetty, Yang Song, Theresa Hodges, Sofie Verbeke (UGent) , Jo Van Dorpe (UGent) , Valerie Fonteyne (UGent) , Bram De Laere (UGent) , Mark V. Mishra, et al.

(2023) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 41(Supplement 6).

Add to list

Journal Article
A1
open access

Management of patients with advanced prostate cancer : part I : intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment : report of the Advanced Prostate Cancer Consensus Conference 2022

Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal Shore, Eric Small, Mathew Smith, et al.

(2023) EUROPEAN UROLOGY. 83(3). p.267-293

Add to list

Success rate of in-bore MRI-guided prostate biopsy based on radical prostatectomy and/or follow-up

Laura Schelfaut, Bart De troyer, Sifrid Hendrickx (UGent) , Charles Van Praet (UGent) , Friedl Vanhaverbeke, Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Hendrik Wynant, Pieter De Visschere (UGent) , Nicolaas Lumen (UGent) , et al.

(2023) European Congress of Radiology 2023 (ECR 2023), Abstracts.

Academic Bibliography

prof. Valerie Fonteyne

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

PI-RADS 5 in prostate magnetic resonance imaging : how important is intraprostatic invasive behavior?

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Definition and diagnosis of oligometastatic bladder cancer : a Delphi consensus study endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Management of patients with advanced prostate cancer : part I : intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment : report of the Advanced Prostate Cancer Consensus Conference 2022

Success rate of in-bore MRI-guided prostate biopsy based on radical prostatectomy and/or follow-up

Contents

Support

Contact